BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 29982877)

  • 1. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
    Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
    Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
    Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
    PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
    Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
    Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
    Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
    Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?
    Preston R; Stuart HM; Lennon R
    Pediatr Nephrol; 2019 Feb; 34(2):195-210. PubMed ID: 29181713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults.
    Gribouval O; Boyer O; Hummel A; Dantal J; Martinez F; Sberro-Soussan R; Etienne I; Chauveau D; Delahousse M; Lionet A; Allard J; Pouteil Noble C; Tête MJ; Heidet L; Antignac C; Servais A
    Kidney Int; 2018 Nov; 94(5):1013-1022. PubMed ID: 30348286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children.
    Vivante A; Chacham OS; Shril S; Schreiber R; Mane SM; Pode-Shakked B; Soliman NA; Koneth I; Schiffer M; Anikster Y; Hildebrandt F
    Pediatr Nephrol; 2019 Sep; 34(9):1607-1613. PubMed ID: 31001663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in KIRREL1, a slit diaphragm component, cause steroid-resistant nephrotic syndrome.
    Solanki AK; Widmeier E; Arif E; Sharma S; Daga A; Srivastava P; Kwon SH; Hugo H; Nakayama M; Mann N; Majmundar AJ; Tan W; Gee HY; Sadowski CE; Rinat C; Becker-Cohen R; Bergmann C; Rosen S; Somers M; Shril S; Huber TB; Mane S; Hildebrandt F; Nihalani D
    Kidney Int; 2019 Oct; 96(4):883-889. PubMed ID: 31472902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the relevance of NUP93 variants in steroid-resistant nephrotic syndrome using next generation sequencing and a fly kidney model.
    Bierzynska A; Bull K; Miellet S; Dean P; Neal C; Colby E; McCarthy HJ; Hegde S; Sinha MD; Bugarin Diz C; Stirrups K; Megy K; Mapeta R; Penkett C; Marsh S; Forrester N; Afzal M; Stark H; BioResource N; Williams M; Welsh GI; Koziell AB; Hartley PS; Saleem MA
    Pediatr Nephrol; 2022 Nov; 37(11):2643-2656. PubMed ID: 35211795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Bierzynska A; McCarthy HJ; Soderquest K; Sen ES; Colby E; Ding WY; Nabhan MM; Kerecuk L; Hegde S; Hughes D; Marks S; Feather S; Jones C; Webb NJ; Ognjanovic M; Christian M; Gilbert RD; Sinha MD; Lord GM; Simpson M; Koziell AB; Welsh GI; Saleem MA
    Kidney Int; 2017 Apr; 91(4):937-947. PubMed ID: 28117080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome.
    Lovric S; Fang H; Vega-Warner V; Sadowski CE; Gee HY; Halbritter J; Ashraf S; Saisawat P; Soliman NA; Kari JA; Otto EA; Hildebrandt F;
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1109-16. PubMed ID: 24742477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational spectrum and novel candidate genes in Chinese children with sporadic steroid-resistant nephrotic syndrome.
    Li J; Wang L; Wan L; Lin T; Zhao W; Cui H; Li H; Cao L; Wu J; Zhang T
    Pediatr Res; 2019 May; 85(6):816-821. PubMed ID: 30712057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
    Miura K; Kaneko N; Hashimoto T; Ishizuka K; Shirai Y; Hisano M; Chikamoto H; Akioka Y; Kanda S; Harita Y; Yamamoto T; Hattori M
    Pediatr Nephrol; 2023 Feb; 38(2):417-429. PubMed ID: 35655039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical genetic testing using a custom-designed steroid-resistant nephrotic syndrome gene panel: analysis and recommendations.
    Sen ES; Dean P; Yarram-Smith L; Bierzynska A; Woodward G; Buxton C; Dennis G; Welsh GI; Williams M; Saleem MA
    J Med Genet; 2017 Dec; 54(12):795-804. PubMed ID: 28780565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of steroid-resistant nephrotic syndrome in the genomic era.
    Bensimhon AR; Williams AE; Gbadegesin RA
    Pediatr Nephrol; 2019 Nov; 34(11):2279-2293. PubMed ID: 30280213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted gene panel for genetic testing of south Indian children with steroid resistant nephrotic syndrome.
    Siji A; Karthik KN; Pardeshi VC; Hari PS; Vasudevan A
    BMC Med Genet; 2018 Nov; 19(1):200. PubMed ID: 30458709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dealing with the incidental finding of secondary variants by the example of SRNS patients undergoing targeted next-generation sequencing.
    Weber S; Büscher AK; Hagmann H; Liebau MC; Heberle C; Ludwig M; Rath S; Alberer M; Beissert A; Zenker M; Hoyer PF; Konrad M; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jan; 31(1):73-81. PubMed ID: 26248470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.
    Li X; Qi D; Wang MY; Ji K; Xie QL; Wang Y; Du SH; Fan HY
    J Ethnopharmacol; 2021 Oct; 279():114351. PubMed ID: 34157324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
    Ruf RG; Lichtenberger A; Karle SM; Haas JP; Anacleto FE; Schultheiss M; Zalewski I; Imm A; Ruf EM; Mucha B; Bagga A; Neuhaus T; Fuchshuber A; Bakkaloglu A; Hildebrandt F;
    J Am Soc Nephrol; 2004 Mar; 15(3):722-32. PubMed ID: 14978175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity.
    Bullich G; Trujillano D; Santín S; Ossowski S; Mendizábal S; Fraga G; Madrid Á; Ariceta G; Ballarín J; Torra R; Estivill X; Ars E
    Eur J Hum Genet; 2015 Sep; 23(9):1192-9. PubMed ID: 25407002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.